Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 0404-9827

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 0404-9827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Bupivacaine Hydrochloride showing its molecular components, including the aromatic ring with methyl groups, a piperidine ring, and bonds to hydrochloride and water molecules.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram of bupivacaine hydrochloride showing its molecular arrangement with hydroxyl groups and an amine side chain.*

FDA Label Image

Image1.jpg (Image1)

A data table showing the concentration of Bupivacaine Hydrochloride Injection, USP without epinephrine, listing concentrations of 0.25%, 0.5%, and 0.75%. It details Bupivacaine Hydrochloride strength in mg/mL as 2.5, 5, and 7.5 respectively, alongside Sodium Chloride amounts in mg/mL as 8.6, 8.1, and 7.6 respectively.*

FDA Label Image

Image2.jpg (Image2)

A data table presenting the concentrations of Bupivacaine Hydrochloride (mg/mL), Epinephrine (mcg/mL), and Sodium Chloride (mg/mL) in Bupivacaine and Epinephrine Injection, USP. The table lists three Bupivacaine HCL concentrations (0.25%, 0.5%, 0.75%) corresponding to 2.5, 5, and 7.5 mg/mL of Bupivacaine Hydrochloride respectively, each with 5 mcg/mL Epinephrine and 8.5 mg/mL Sodium Chloride.*

FDA Label Image

Image3.jpg (Image3)

A table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes and examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other Drugs, with corresponding example drugs such as bupivacaine under Local anesthetics.*

FDA Label Image

Image4.jpg (Image4)

A data table showing dosage information for various types of nerve blocks using Bupivacaine Hydrochloride injection. It details concentration, volume (mL), corresponding dose (mg), and the extent of motor block effect for each block type including local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, and test dose with epinephrine.*

FDA Label Image

Image5.jpg (Image5)

A data table listing various units of sale for Bupivacaine Hydrochloride injection solutions with corresponding concentrations. The table details different NDC codes, vial types (single-dose or multiple-dose teartop and fliptop), tray sizes of 25 vials, and concentrations ranging from 0.25% to 0.75%, with specific mg/ml and volume information. It also includes pH ranges from 4.0 to 6.5 for each product.*

FDA Label Image

Image6.jpg (Image6)

Table listing various NDCs, units of sale, and concentrations for a drug product at 0.25% concentration, 25 mg per 10 ml (2.5 mg/ml), with pH 3.3 to 5.5. Units of sale include cartons and trays of single-dose teartop vials, and cases of individually packaged multiple-dose fliptop vials.*

FDA Label Image

Label1.jpg (Label1)

Label of Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a multiple dose fliptop vial, 50 mL total volume (250 mg/50 mL). The label indicates use for nerve block, not for caudal, epidural, or spinal anesthesia, with instructions to use aseptic technique. Manufactured and packaged by Henry Schein, Inc. Includes storage recommendations and various regulatory codes such as NDC 0404-9827-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.